The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DCC-3116 in combination with ripretinib for patients with advanced gastrointestinal stromal tumor: A phase 1/2 study.
 
Sreenivasa R Chandana
Speakers' Bureau - Natera
Research Funding - Abbvie (Inst); Adcentrx Therapeutics (Inst); Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Cardiff Oncology (Inst); Dicephera Pharmaceuticals, Inc. (Inst); Elevation Oncology (Inst); Exact Sciences (Inst); Genentech/Roche (Inst); IDEAYA Biosciences (Inst); IgM Biosciences (Inst); Incyte (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novocure (Inst); Pfizer (Inst); Qualigen Therapeutics (Inst); Zymeworks (Inst)
 
Dale Randall Shepard
Honoraria - Deciphera
Consulting or Advisory Role - AADi; Deciphera; Sanofi; SpringWorks Therapeutics
Research Funding - aadi (Inst); Abbisko Therapeutics (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cogent Biosciences (Inst); Compugen (Inst); Conjupro Biotherapeutics (Inst); Deciphera (Inst); Genentech/Roche (Inst); Harpoon therapeutics (Inst); InhibRx (Inst); Kinnate Biopharma (Inst); Lilly (Inst); MabSpace Biosciences (Inst); Novartis (Inst); Pfizer (Inst); Pionyr (Inst); PMV Pharma (Inst); Prelude Therapeutics (Inst); Seattle Genetics/Astellas (Inst); Shanghai Miracogen Inc. (Inst); tempus (Inst); VBL Therapeutics (Inst)
 
Janice M. Mehnert
Stock and Other Ownership Interests - Pfizer
Honoraria - HMP; Medscape
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Sanofi/Regeneron; Seagen
Research Funding - Amgen (Inst); AstraZeneca (Inst); bristol myers squibb (Inst); GV20 Therapeutics; Incyte (Inst); Kinnate Biopharma (Inst); macrogenics (Inst); macrogenics (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Ping Chi
Stock and Other Ownership Interests - ORIC Pharmaceuticals (I)
Consulting or Advisory Role - Deciphera; NewBay Pharma
Research Funding - Deciphera (Inst); NewBay Pharma (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from ORIC (I)
Travel, Accommodations, Expenses - NewBay Pharma
 
Jonathan C. Trent
Consulting or Advisory Role - AADi; Agios; Bayer; Blueprint Medicines; Boehringer Ingelheim; C4 Therapeutics; Cogent Medicine; Daiichi Sankyo; Deciphera; Epizyme; Foghorn Therapeutics; SERVIER
 
Charles M Psoinos
Employment - Biogen; Deciphera
Stock and Other Ownership Interests - Abbvie; Deciphera; Johnson & Johnson/Janssen; Pfizer; Viatris
 
Bo Zhou
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Vandy Black
Employment - Deciphera; Deciphera; FORMA Therapeutics; Novo Nordisk
Stock and Other Ownership Interests - Deciphera
Consulting or Advisory Role - University of Florida
Travel, Accommodations, Expenses - Deciphera
 
Lakshmi Viswanathan
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Maricel Gozo
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Erika Davis
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
 
Rodrigo Ruiz-Soto
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera; Immunogen
Patents, Royalties, Other Intellectual Property - I am an inventor in 3 patents with Immunogen, I transferred the rights to Immunogen. I have not received (and I will not receive) any royalties; I am an inventor in pending patents at Deciphera. I have transferred the rights to Deciphera, I have not received (and will not receive) any royalties
 
Matthew L. Sherman
Employment - Deciphera
Leadership - Deciphera; Pieris Pharmaceuticals
Stock and Other Ownership Interests - Deciphera; Pieris Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Acceleron Pharma
 
Frederic J. Reu
Employment - Deciphera
Leadership - Deciphera
Stock and Other Ownership Interests - Bristol-Myers Squibb; Deciphera
 
Michael C. Heinrich
Honoraria - Novartis
Consulting or Advisory Role - Cogent Pharmaceuticals; Deciphera; Novartis; Theseus Pharmaceuticals
Research Funding - Cogent Biosciences
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)